MNMD |
Mind Medicine (MindMed) Inc. |
0 |
11.43% |
|
|
|
|
|
N/A |
0.00% |
97.75% |
24.00% |
---|
NRXP |
NRx Pharmaceuticals, Inc. |
0 |
10.81% |
|
|
|
|
|
N/A |
0.00% |
258.09% |
35.66% |
---|
|
BLACKROCK TREASURY TRUST INSTL 62 |
|
10.12% |
|
|
|
|
|
|
|
|
|
---|
CYBN |
Cybin Inc. |
0 |
7.08% |
|
|
|
|
|
N/A |
0.00% |
654.88% |
10.35% |
---|
ATAI |
Atai Life Sciences N.V. |
0 |
6.56% |
|
|
|
|
|
N/A |
0.00% |
206.79% |
28.23% |
---|
ALKS |
Alkermes plc |
0 |
6.00% |
|
|
|
|
|
N/A |
0.00% |
55.46% |
60.80% |
---|
IXHL |
Incannex Healthcare Limited |
0 |
5.56% |
|
|
|
|
|
N/A |
0.00% |
N/A |
N/A |
---|
VTGN |
VistaGen Therapeutics, Inc. |
0 |
4.66% |
|
|
|
|
|
N/A |
0.00% |
214.44% |
15.86% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
0 |
4.39% |
|
|
|
|
|
N/A |
0.00% |
34.71% |
19.89% |
---|
ITCI |
INTRA-CELLULAR THERAPIES INC |
|
4.32% |
|
|
|
|
|
|
|
|
|
---|
SAGE |
Sage Therapeutics, Inc. |
0 |
4.11% |
|
|
|
|
|
N/A |
0.00% |
81.36% |
58.82% |
---|
QNTM |
QUANTUM BIOPHARMA LTD |
|
4.03% |
|
|
|
|
|
|
|
|
|
---|
GHRS |
GH Research PLC |
0 |
3.99% |
|
|
|
|
|
N/A |
0.00% |
644.27% |
24.11% |
---|
CMPS |
COMPASS Pathways plc |
0 |
3.99% |
|
|
|
|
|
N/A |
0.00% |
216.18% |
86.97% |
---|
CMND |
Clearmind Medicine Inc. |
0 |
3.67% |
|
|
|
|
|
N/A |
0.00% |
N/A |
N/A |
---|
ENVB |
Enveric Biosciences, Inc. |
0 |
3.41% |
|
|
|
|
|
N/A |
0.00% |
387.37% |
100.00% |
---|
DRUG |
Bright Minds Biosciences Inc. |
0 |
1.75% |
|
|
|
|
|
N/A |
0.00% |
N/A |
N/A |
---|
RLMD |
Relmada Therapeutics, Inc. |
0 |
1.73% |
|
|
|
|
|
N/A |
0.00% |
311.33% |
56.27% |
---|
NUMIF |
NUMINUS WELLNESS INC |
|
1.02% |
|
|
|
|
|
|
|
|
|
---|
PBM |
PSYENCE BIOMEDICAL LTD |
|
0.90% |
|
|
|
|
|
|
|
|
|
---|
STIM |
Neuronetics, Inc. |
0 |
0.29% |
|
|
|
|
|
N/A |
0.00% |
188.95% |
57.40% |
---|
SEELQ |
SEELOS THERAPEUTICS INC |
|
0.08% |
|
|
|
|
|
|
|
|
|
---|
LSDIF |
LUCY SCIENTIFIC DISCOVERY IN |
|
0.01% |
|
|
|
|
|
|
|
|
|
---|
FTHWF |
FIELD TRIP HEALTH & WELLNESS |
|
N/A |
|
|
|
|
|
|
|
|
|
---|
PSYBF |
PSYBIO THERAPEUTICS CORP |
|
N/A |
|
|
|
|
|
|
|
|
|
---|